CRISPR

CRISPR1-necab2

ID
ZDB-CRISPR-230130-14
Name
CRISPR1-necab2
Previous Names
None
Target
Sequence
5' - GGGCTTCGCGCCGGAGCCTCGAA - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
The first three "G"s were added
Genome Resources
None
Target Location
Constructs
No data available
Genomic Features
Genomic Feature Affected Genomic Regions
s4301 necab2
Expression
Gene expression in Wild Types + CRISPR1-necab2
No data available
Phenotype
Phenotype resulting from CRISPR1-necab2
No data available
Phenotype of all Fish created by or utilizing CRISPR1-necab2
Phenotype Fish Conditions Figures
head necab1 expression increased amount, abnormal necab2s4301/s4301 standard conditions Fig. 3 with image from Chen et al., 2022
head necab2 expression decreased amount, abnormal necab2s4301/s4301 standard conditions Fig. 3 with image from Chen et al., 2022
G protein-coupled serotonin receptor signaling pathway increased occurrence, abnormal necab2s4301/s4301 standard conditions Fig. 6 with image from Chen et al., 2022
G-protein beta/gamma-subunit complex binding increased occurrence, abnormal necab2s4301/s4301 standard conditions Fig. 6 with image from Chen et al., 2022
locomotory behavior decreased process quality, abnormal necab2s4301/s4301 standard conditions Fig. 5 with image from Chen et al., 2022
male organism social behavior decreased process quality, abnormal necab2s4301/s4301 standard conditions Fig. 5 with image from Chen et al., 2022
G protein-coupled receptor signaling pathway increased occurrence, abnormal necab2s4301/s4301 standard conditions Fig. 6 with image from Chen et al., 2022
phospholipase C-activating G protein-coupled receptor signaling pathway increased occurrence, abnormal necab2s4301/s4301 standard conditions Fig. 6 with image from Chen et al., 2022
thigmotaxis decreased process quality, abnormal necab2s4301/s4301 standard conditions Fig. 5 with image from Chen et al., 2022
nervous system development normal process quality, abnormal necab2s4301/s4301; s4305Tg/s4305Tg standard conditions Fig. 4 with image from Chen et al., 2022
cerebellum plasma membrane EGFP expression increased amount, abnormal necab2s4301/s4301; s4304Tg/s4304Tg; s4305Tg/s4305Tg standard conditions Fig. 7 with image from Chen et al., 2022
cerebellum cytoplasm EGFP expression decreased amount, abnormal necab2s4301/s4301; s4304Tg/s4304Tg; s4305Tg/s4305Tg standard conditions Fig. 7 with image from Chen et al., 2022
cerebellum cytoplasm mCherry expression decreased amount, abnormal necab2s4301/s4301; s4304Tg/s4304Tg; s4305Tg/s4305Tg standard conditions Fig. 7 with image from Chen et al., 2022
cerebellum plasma membrane mCherry expression increased amount, abnormal necab2s4301/s4301; s4304Tg/s4304Tg; s4305Tg/s4305Tg standard conditions Fig. 7 with image from Chen et al., 2022
Citations